Literature DB >> 19586953

Large crystal growth by thermal control allows combined X-ray and neutron crystallographic studies to elucidate the protonation states in Aspergillus flavus urate oxidase.

E Oksanen1, M P Blakeley, F Bonneté, M T Dauvergne, F Dauvergne, M Budayova-Spano.   

Abstract

Urate oxidase (Uox) catalyses the oxidation of urate to allantoin and is used to reduce toxic urate accumulation during chemotherapy. X-ray structures of Uox with various inhibitors have been determined and yet the detailed catalytic mechanism remains unclear. Neutron crystallography can provide complementary information to that from X-ray studies and allows direct determination of the protonation states of the active-site residues and substrate analogues, provided that large, well-ordered deuterated crystals can be grown. Here, we describe a method and apparatus used to grow large crystals of Uox (Aspergillus flavus) with its substrate analogues 8-azaxanthine and 9-methyl urate, and with the natural substrate urate, in the presence and absence of cyanide. High-resolution X-ray (1.05-1.20 A) and neutron diffraction data (1.9-2.5 A) have been collected for the Uox complexes at the European Synchrotron Radiation Facility and the Institut Laue-Langevin, respectively. In addition, room temperature X-ray data were also collected in preparation for joint X-ray and neutron refinement. Preliminary results indicate no major structural differences between crystals grown in H(2)O and D(2)O even though the crystallization process is affected. Moreover, initial nuclear scattering density maps reveal the proton positions clearly, eventually providing important information towards unravelling the mechanism of catalysis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19586953      PMCID: PMC2843968          DOI: 10.1098/rsif.2009.0162.focus

Source DB:  PubMed          Journal:  J R Soc Interface        ISSN: 1742-5662            Impact factor:   4.118


  38 in total

1.  A preliminary time-of-flight neutron diffraction study of Streptomyces rubiginosus D-xylose isomerase.

Authors:  B Leif Hanson; Paul Langan; Amy K Katz; Xinmin Li; Joel M Harp; Jenny P Glusker; Benno P Schoenborn; Gerard J Bunick
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2004-01-23

2.  Solvent content of protein crystals.

Authors:  B W Matthews
Journal:  J Mol Biol       Date:  1968-04-28       Impact factor: 5.469

3.  The effect of D2-O on the thermal stability of proteins. Thermodynamic parameters for the transfer of model compounds from H2-O to D2-O.

Authors:  G C Kresheck; H Schneider; H A Scheraga
Journal:  J Phys Chem       Date:  1965-09

4.  Protein crystallography under xenon and nitrous oxide pressure: comparison with in vivo pharmacology studies and implications for the mechanism of inhaled anesthetic action.

Authors:  Nathalie Colloc'h; Jana Sopkova-de Oliveira Santos; Pascal Retailleau; Denis Vivarès; Françoise Bonneté; Béatrice Langlois d'Estainto; Bernard Gallois; Alain Brisson; Jean-Jacques Risso; Marc Lemaire; Thierry Prangé; Jacques H Abraini
Journal:  Biophys J       Date:  2006-10-06       Impact factor: 4.033

Review 5.  Neutron protein crystallography: current status and a brighter future.

Authors:  Dean A A Myles
Journal:  Curr Opin Struct Biol       Date:  2006-09-11       Impact factor: 6.809

6.  An investigation into the protonation states of the C1 domain of cardiac myosin-binding protein C.

Authors:  S J Fisher; J R Helliwell; S Khurshid; L Govada; C Redwood; J M Squire; N E Chayen
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2008-05-14

7.  Ultrahigh resolution drug design I: details of interactions in human aldose reductase-inhibitor complex at 0.66 A.

Authors:  E I Howard; R Sanishvili; R E Cachau; A Mitschler; B Chevrier; P Barth; V Lamour; M Van Zandt; E Sibley; C Bon; D Moras; T R Schneider; A Joachimiak; A Podjarny
Journal:  Proteins       Date:  2004-06-01

8.  Complexed and ligand-free high-resolution structures of urate oxidase (Uox) from Aspergillus flavus: a reassignment of the active-site binding mode.

Authors:  Pascal Retailleau; Nathalie Colloc'h; Denis Vivarès; Françoise Bonneté; Bertrand Castro; Mohamed El-Hajji; Jean Paul Mornon; Gérald Monard; Thierry Prangé
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2004-02-25

Review 9.  Neutron crystallography: opportunities, challenges, and limitations.

Authors:  Matthew P Blakeley; Paul Langan; Nobuo Niimura; Alberto Podjarny
Journal:  Curr Opin Struct Biol       Date:  2008-08-07       Impact factor: 6.809

10.  Crystallization of a large single crystal of cubic insulin for neutron protein crystallography.

Authors:  M Maeda; T Chatake; I Tanaka; A Ostermann; N Niimura
Journal:  J Synchrotron Radiat       Date:  2003-11-28       Impact factor: 2.616

View more
  5 in total

1.  Biological physics at large facilities: from molecule to cell.

Authors:  Giuseppe Zaccai
Journal:  J R Soc Interface       Date:  2009-07-29       Impact factor: 4.118

2.  Large-volume protein crystal growth for neutron macromolecular crystallography.

Authors:  Joseph D Ng; James K Baird; Leighton Coates; Juan M Garcia-Ruiz; Teresa A Hodge; Sijay Huang
Journal:  Acta Crystallogr F Struct Biol Commun       Date:  2015-03-30       Impact factor: 1.056

3.  Preliminary joint X-ray and neutron protein crystallographic studies of endoxylanase II from the fungus Trichoderma longibrachiatum.

Authors:  Andrey Y Kovalevsky; B Leif Hanson; Sean Seaver; S Zoë Fisher; Marat Mustyakimov; Paul Langan
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2011-01-27

4.  Design, synthesis, and molecular docking of cysteine-based sulphonamide derivatives as antimicrobial agents.

Authors:  Melford C Egbujor; Uchechukwu C Okoro; Sunday N Okafor; Samuel A Egu; Ifeanyi S Amasiatu; Pius I Egwuatu; Odera R Umeh; Eziafakaego M Ibo
Journal:  Res Pharm Sci       Date:  2021-11-11

5.  The neutron structure of urate oxidase resolves a long-standing mechanistic conundrum and reveals unexpected changes in protonation.

Authors:  Esko Oksanen; Matthew P Blakeley; Mohamed El-Hajji; Ulf Ryde; Monika Budayova-Spano
Journal:  PLoS One       Date:  2014-01-23       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.